Results 271 to 280 of about 53,301 (333)

Acid Suppression in Mild‐Moderate Laryngomalacia Without GERD: A Randomized Controlled Trial

open access: yesThe Laryngoscope, Volume 136, Issue 1, Page 471-478, January 2026.
Infants ≤ 6 months old with mild to moderate laryngomalacia at a tertiary children's hospital were randomized to famotidine and feeding modifications (AST) or feeding modifications alone (no‐AST). Patients randomized to AST (n = 20) and no‐AST (n = 20) had comparable improvement on Laryngomalacia Airway Symptom Score and Infant Gastroesophageal Reflux ...
Amber D. Shaffer   +8 more
wiley   +1 more source

Role of Gynecologic Findings in Interstitial Cystitis/Bladder Pain Syndrome: A Consensus

open access: yesNeurourology and Urodynamics, Volume 45, Issue 1, Page 39-45, January 2026.
ABSTRACT Objective To evaluate the role of gynecologic findings in Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS) by reviewing current international guidelines and identifying relevant gynecologic co‐morbidities. Methods This consensus statement was developed through a systematic four‐phase process: (1) comprehensive literature review across ...
Marie E. Sullivan   +5 more
wiley   +1 more source

Development of Magnetic Nanoparticle‐Added Cryogel Membrane Materials for the Removal of Pharmaceutical Wastes

open access: yesNatural Sciences, Volume 6, Issue 1, January 2026.
Magnetic mg‐Fe3O4‐APTES nanoparticle‐doped p(HEMA)‐phenylboronic acid cryogel membranes are developed for the efficient removal of dopamine from pharmaceutical wastewater. Utilizing boronate affinity interactions, the system demonstrates a high adsorption capacity of 1969.1 mg/g and eliminates 81.3% of the target molecule within 15 minutes.
Cansu İlke Kuru‐Sumer   +2 more
wiley   +1 more source

Piperazine Derivatives: A Privileged Scaffold in Modern Synthesis and Medicinal Chemistry

open access: yesChemistryOpen, Volume 15, Issue 1, January 2026.
Piperazine‐based bioactive molecules represent a versatile class of compounds with broad therapeutic potential. Structural modification of the piperazine scaffold governs key structure–activity relationships, enabling antibacterial, antifungal, antitumor, neuroactive, and anti‐inflammatory activities.
Assel Ten   +5 more
wiley   +1 more source

Activity‐restoring mutations in the histamine H3 receptor increase constitutive activity and reduce structural stability

open access: yesProtein Science, Volume 35, Issue 1, January 2026.
Abstract The histamine H3 receptor (H3R) is a class A G protein‐coupled receptor (GPCR) that regulates neurotransmitter release in the central nervous system. Although structures of H3R in both inactive and active states have been elucidated, the functional roles of specific residues remain unclear.
Ami Nakajima   +6 more
wiley   +1 more source

Histamine H1 receptor inverse agonists improve structure and pain in an osteoarthritis mouse model. [PDF]

open access: yesJ Clin Invest
Kurakazu I   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy